Literature DB >> 11473375

Status of hyperthermia in the treatment of advanced liver cancer.

P Moroz1, S K Jones, B N Gray.   

Abstract

The vast majority of patients with malignant liver tumors have inoperable disease. These patients must rely on chemotherapy, radiotherapy, and various locoregional treatments. Although these treatments have demonstrated encouraging response rates, symptom palliation and occasional down staging of tumors, their impact on survival is minor. As a result there has been renewed interest in hyperthermia as a treatment option. This study reviews the current modalities of hyperthermia in terms of clinical results, side effects, limitations, and therapeutic standing. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11473375     DOI: 10.1002/jso.1106

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Noninvasive thermometry assisted by a dual-function ultrasound transducer for mild hyperthermia.

Authors:  Chun-Yen Lai; Dustin E Kruse; Charles F Caskey; Douglas N Stephens; Patrick L Sutcliffe; Katherine W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-12       Impact factor: 2.725

Review 2.  Radiofrequence ablation of liver cancers.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Optical signatures of radiofrequency ablation in biological tissues.

Authors:  Pranav Lanka; Kalloor Joseph Francis; Hindrik Kruit; Andrea Farina; Rinaldo Cubeddu; Sanathana Konugolu Venkata Sekar; Srirang Manohar; Antonio Pifferi
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

4.  Focused RF hyperthermia using magnetic fluids.

Authors:  T Onur Tasci; Ibrahim Vargel; Anil Arat; Elif Guzel; Petek Korkusuz; Ergin Atalar
Journal:  Med Phys       Date:  2009-05       Impact factor: 4.071

5.  3D viability imaging of tumor phantoms treated with single-walled carbon nanohorns and photothermal therapy.

Authors:  Jon Whitney; Matthew DeWitt; Bryce M Whited; William Carswell; Alex Simon; Christopher G Rylander; Marissa Nichole Rylander
Journal:  Nanotechnology       Date:  2013-06-18       Impact factor: 3.874

6.  Permalloy-Based Thin Film Structures: Magnetic Properties and the Giant Magnetoimpedance Effect in the Temperature Range Important for Biomedical Applications.

Authors:  Anna A Chlenova; Alexey A Moiseev; Mikhail S Derevyanko; Aleksandr V Semirov; Vladimir N Lepalovsky; Galina V Kurlyandskaya
Journal:  Sensors (Basel)       Date:  2017-08-17       Impact factor: 3.576

7.  Water-Based Suspensions of Iron Oxide Nanoparticles with Electrostatic or Steric Stabilization by Chitosan: Fabrication, Characterization and Biocompatibility.

Authors:  Galina V Kurlyandskaya; Larisa S Litvinova; Alexander P Safronov; Valeria V Schupletsova; Irina S Tyukova; Olga G Khaziakhmatova; Galina B Slepchenko; Kristina A Yurova; Elena G Cherempey; Nikita A Kulesh; Ricardo Andrade; Igor V Beketov; Igor A Khlusov
Journal:  Sensors (Basel)       Date:  2017-11-13       Impact factor: 3.576

Review 8.  Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review.

Authors:  E Y K Ng; S D Kumar
Journal:  Biomed Eng Online       Date:  2017-03-23       Impact factor: 2.819

9.  Solving the Time- and Frequency-Multiplexed Problem of Constrained Radiofrequency Induced Hyperthermia.

Authors:  Andre Kuehne; Eva Oberacker; Helmar Waiczies; Thoralf Niendorf
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

10.  Polyacrylamide Ferrogels with Magnetite or Strontium Hexaferrite: Next Step in the Development of Soft Biomimetic Matter for Biosensor Applications.

Authors:  Alexander P Safronov; Ekaterina A Mikhnevich; Zahra Lotfollahi; Felix A Blyakhman; Tatyana F Sklyar; Aitor Larrañaga Varga; Anatoly I Medvedev; Sergio Fernández Armas; Galina V Kurlyandskaya
Journal:  Sensors (Basel)       Date:  2018-01-16       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.